These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 7878919

  • 1. Abrogation of accelerated allograft rejection by intrathymic injection of donor spleen cells is associated with upregulation of donor-reactive IgM, IgG1, and IgG2A, but depression of IgG2B in the circulation and at the graft site.
    Binder J, Hancock WW, Watschinger B, Wasowska B, Sayegh MH, Kupiec-Weglinski JW.
    Transplant Proc; 1995 Feb; 27(1):138-41. PubMed ID: 7878919
    [No Abstract] [Full Text] [Related]

  • 2. The alloantibody network following intrathymic immunomodulation of sensitized rat recipients of cardiac allografts.
    Binder J, Hancock WW, Watschinger B, Wasowska B, Sayegh MH, Kupiec-Weglinski JW.
    Transplantation; 1995 Feb 27; 59(4):590-7. PubMed ID: 7878763
    [Abstract] [Full Text] [Related]

  • 3. Intrathymic immunomodulation in sensitized rat recipients of cardiac allografts: requirements for allorecognition pathways.
    Stadlbauer TH, Schaub M, Magee CC, Kupiec-Weglinski JW, Sayegh MH.
    J Heart Lung Transplant; 2000 Jun 27; 19(6):566-75. PubMed ID: 10867337
    [Abstract] [Full Text] [Related]

  • 4. Intrathymic injection of donor-specific X-irradiation-sensitive spleen cells abrogates accelerated rejection of cardiac allografts in sensitized rats.
    Binder J, Sayegh MH, Watschinger B, Hancock WW, Kupiec-Weglinski JW.
    Transplantation; 1994 Jul 15; 58(1):80-6. PubMed ID: 8036712
    [Abstract] [Full Text] [Related]

  • 5. Donor-specific transfusion does not mitigate but accelerates rejection of intravenously transplanted lymphocytes.
    Jaskłowska-Englisz M, Podgórska D, Adamczyk G, Olszewski WL.
    Arch Immunol Ther Exp (Warsz); 1993 Jul 15; 41(5-6):365-71. PubMed ID: 8010878
    [Abstract] [Full Text] [Related]

  • 6. Induction of tolerance in rat cardiac allograft model by intrathymic injection of donor bone marrow cells.
    Ito A, Ito T, Kamiike W, Nozaki S, Uchikoshi F, Tanaka T, Kuhara A, Moriguchi A, Miyata M, Nakata S.
    Transplant Proc; 1995 Apr 15; 27(2):1607-8. PubMed ID: 7536974
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Protection of heart and rejection of lymphocyte allografts from the same donor in recipients of donor-specific transfusions.
    Jaskłowska-Englisz M, Olszewski WL, Maksymowicz M, Ziółkowska A.
    Ann Transplant; 1998 Apr 15; 3(1):28-33. PubMed ID: 9869895
    [Abstract] [Full Text] [Related]

  • 10. Effect of simultaneous intrathymic injection of two unrelated cellular alloantigens on rat cardiac allograft survival.
    Shimomura K, Hardy MA, Oluwole SF.
    Transplant Proc; 1995 Feb 15; 27(1):127. PubMed ID: 7878878
    [No Abstract] [Full Text] [Related]

  • 11. Cytokine and alloantibody networks in long-term cardiac allografts in rapamycin-treated sensitized rat recipients.
    Wasowska B, Wieder KJ, Hancock WW, Berse B, Binder J, Strom TB, Kupiec-Weglinski JW.
    Transplant Proc; 1995 Feb 15; 27(1):423-6. PubMed ID: 7879047
    [No Abstract] [Full Text] [Related]

  • 12. Induction of tolerance by intrathymic injection of donor bone marrow cells in the rat: simultaneous heart and skin allograft model.
    Imanishi M, Matsuura T, Hara Y, Tahara H, Kurita T.
    Transplant Proc; 1994 Aug 15; 26(4):1958-9. PubMed ID: 7520615
    [No Abstract] [Full Text] [Related]

  • 13. Intrathymic injection of allogeneic cells induces indefinite survival of cardiac but not small bowel grafts.
    Xia W, Sayegh MH, Kirkman RL.
    Transplant Proc; 1994 Jun 15; 26(3):1581. PubMed ID: 8030045
    [No Abstract] [Full Text] [Related]

  • 14. Rapamycin abrogates accelerated rejection in sensitized rats by selectively suppressing intragraft cell activation, adhesion/binding properties, and modulating serum alloantibody responses.
    Schmidbauer G, Hancock WW, Wasowska B, Binder J, Padberg W, Kupiec-Weglinski JW.
    Transplant Proc; 1995 Feb 15; 27(1):427-9. PubMed ID: 7879048
    [No Abstract] [Full Text] [Related]

  • 15. Downregulation of intragraft IFN-gamma expression correlates with increased IgG1 alloantibody response following intrathymic immunomodulation of sensitized rat recipients.
    Binder J, Graser E, Hancock WW, Wasowska B, Sayegh MH, Volk HD, Kupiec-Weglinski JW.
    Transplantation; 1995 Dec 27; 60(12):1516-24. PubMed ID: 8545884
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Reduction in donor-specific cytotoxic T lymphocytes and prolonged cardiac allograft survival following intrathymic donor splenocyte injection.
    Goss JA, Nakafusa Y, Yu S, Flye MW.
    Transplant Proc; 1993 Feb 27; 25(1 Pt 1):286-8. PubMed ID: 8438302
    [No Abstract] [Full Text] [Related]

  • 18. CD4 mAb therapy modulates alloantibody production and intracardiac graft deposition in association with selective inhibition of Th1 lymphokines.
    Kupiec-Weglinski JW, Wasowska B, Papp I, Schmidbauer G, Sayegh MH, Baldwin WM, Wieder KJ, Hancock WW.
    J Immunol; 1993 Nov 01; 151(9):5053-61. PubMed ID: 8409456
    [Abstract] [Full Text] [Related]

  • 19. Distinct tolerance pathways in sensitized rat recipients after blockade of activation signal 1 and signal 2.
    Onodera K, Chandraker A, Kato H, Volk HD, Sayegh MH, Kupiec-Weglinski JW.
    Transplant Proc; 1999 Nov 01; 31(1-2):876-7. PubMed ID: 10083384
    [No Abstract] [Full Text] [Related]

  • 20. Intrathymic injection of alloantigen may lead to hyperacute rejection and prolonged graft survival of heart allografts in the rat.
    de Bruin RW, van Rossum TJ, Scheringa M, Bonthuis F, IJzermans JN, Marquet RL.
    Transplantation; 1995 Nov 15; 60(9):1061-3. PubMed ID: 7491686
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.